EQUITY (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Common stock, shares outstanding	39,687,589		39,687,589
Common stock par value	$ 0.01		$ 0.01		$ 0.01
Number of options granted during period			145,770
Number of options exercised
Intrinsic value of options outstanding	$ 126,000		$ 126,000		$ 291,000
Intrinsic value of options exercisable	114,000		114,000
Compensation cost, non-vested awards not yet recognized	59,000		59,000
Selling, General and Administrative Expenses [Member]
Subsidiary, Sale of Stock [Line Items]
Stock based compensation expense	$ 22,000	$ 21,000	$ 53,000	$ 36,000
Non Employee Stock Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options exercised	0		0
Chief Financial Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options granted during period	50,000		50,000
Director [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options granted during period			30,000
Chief Executive Officer [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options granted during period			35,000
Other Employees [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options granted during period			30,770
Non-employee [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options granted during period	0		0
Amended and Restated 2006 Stock Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of options available for grant	1,434,850		1,434,850